These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4036746)

  • 1. [Long-term administration of ceftriaxone (Ro 13-9904) to complicated urinary tract infections].
    Oishi K; Kawakita M; Hida S; Higashi Y; Yamauchi T; Yoshida O
    Hinyokika Kiyo; 1985 Apr; 31(4):711-21. PubMed ID: 4036746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of complicated urinary tract infections with the long acting cephalosporin, ceftriaxone.
    Rothwell DL; Bremner DA; Taylor KM
    N Z Med J; 1983 May; 96(732):392-4. PubMed ID: 6302612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and fundamental studies on ceftriaxone (CTRX) against urinary tract infections].
    Nishio S; Yoshihara H
    Hinyokika Kiyo; 1988 May; 34(5):937-42. PubMed ID: 3177133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone for once-a-day therapy of urinary tract infections.
    Childs SJ; Wells WG; Mirelman S
    Am J Med; 1984 Oct; 77(4C):73-6. PubMed ID: 6093524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of cefmenoxime (CMX) for complicated urinary tract infection].
    Tsuchida S; Sasaki S; Takada H; Miyagata S; Sato S; Shimizu S; Sakamoto F; Kizu N
    Hinyokika Kiyo; 1985 Feb; 31(2):365-74. PubMed ID: 3859998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies on ceftriaxone in complicated urinary tract infections].
    Yamakawa K; Hioki T; Kawamura J
    Hinyokika Kiyo; 1989 Feb; 35(2):377-82. PubMed ID: 2735247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single daily dose treatment of severe refractory infections with ceftriaxone. Cost savings and possible parenteral outpatient treatment.
    Baumgartner JD; Glauser MP
    Arch Intern Med; 1983 Oct; 143(10):1868-73. PubMed ID: 6312914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of ceftriaxone in the pediatric field].
    Hoshina H; Hirosawa H; Mikuni K; Ichihashi H
    Jpn J Antibiot; 1984 Nov; 37(11):2027-33. PubMed ID: 6098699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW; Snow RM
    Am J Med; 1984 Oct; 77(4C):63-7. PubMed ID: 6093522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of ceftriaxone.
    File TM; Tan JS; Salstrom SJ
    Clin Ther; 1984; 6(5):653-61. PubMed ID: 6090021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
    McCloskey RV
    Am J Med; 1984 Oct; 77(4C):97-103. PubMed ID: 6093528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone: therapeutic results in various infections and kinetic studies.
    Giamarellou HJ; Tsagarakis J; Petrikkos G; Mavroudis K; Veldekis D; Daikos GK
    Arzneimittelforschung; 1984; 34(3):321-5. PubMed ID: 6329238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experience of norfloxacin in urinary tract infection].
    Banya Y; Funaki H; Takagane H; Tanji S; Abe T; Aoki H; Kubo T; Ohori T
    Hinyokika Kiyo; 1985 Aug; 31(8):1501-17. PubMed ID: 4083210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections].
    Martínez Jabaloyas JM; Sanz Chinesta S; Jiménez Cruz JF; Flores Corral N; Unda Urzaiz M; Leiva Galvis O; González Romojaro V; Hernández Fernández C; Lledó García E; Rioja Sanz LA; Gonzalvo Ibarra A; Camacho González JE; Ruíz Alvárez-Cienfuegos F; Resel Estévez L; Corral Saleta J; Burgos Rodríguez R; Del Rosal Samaniego JM
    Actas Urol Esp; 1997; 21(7):668-74. PubMed ID: 9412209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftriaxone in the treatment of serious infections, particularly after surgery.
    Scully BE; Neu HC
    Am J Surg; 1984 Oct; 148(4A):35-40. PubMed ID: 6091479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and pharmacokinetic study of ceftriaxone in pediatric bacterial infections].
    Meguro H; Nonaka C; Kawaoi T; Takahashi S; Fujii R; Arimasu O
    Jpn J Antibiot; 1984 Nov; 37(11):2049-59. PubMed ID: 6098701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experience with cefmenoxime (CMX) in complicated urinary tract infections].
    Minami Y; Kanda S; Matsuo R; Sakai H; Kamemoto H; Hisamatsu A; Maruta N; Johdai A; Shimomae H; Watanabe Y
    Hinyokika Kiyo; 1985 Jun; 31(6):1077-84. PubMed ID: 3864365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term treatment and clinical evaluation of enoxacin in complicated urinary tract infections].
    Washida H; Sakagami H; Iwase Y; Sasaki S
    Hinyokika Kiyo; 1987 Sep; 33(9):1508-12. PubMed ID: 3481218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of cefotiam in adults urinary tract infections (author's transl)].
    Guibert J; Coppens H; Yvelin C
    Pathol Biol (Paris); 1982 Jun; 30(6):353-6. PubMed ID: 6287388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical studies of norfloxacin in urinary tract infections].
    Matsuura T; Kurita T
    Hinyokika Kiyo; 1985 Nov; 31(11):2085-9. PubMed ID: 4091145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.